YOUR BUSINESS AUTHORITY
Springfield, MO
Novartis AG announced it would purchase Endocyte Inc. for $2.1 billion.
The acquisition would give the Swiss pharmaceutical company access to Endocyte's so-called radiopharmaceuticals, which carry radioactive substances to kill tumor cells.
Endocyte is currently developing a new treatment for prostate cancer.
Read more from The Wall Street Journal.
The Republic School District is on track to open its Intermediate School for fifth- and sixth-grade students for the 2025-26 academic year.
Legacy Bank president exits amid investigation into 'employee-related allegations'
Chick N Max plans Springfield debut
Executive director hired at The Victim Center
Biblical history attraction planned at former Andy Williams theater
Developer seeks approval of C-Street project, including Missouri Hotel renovation
Photo Gallery: New Fire in the Hole debuts at Silver Dollar City